Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, Australia; Centre for Youth Mental Health, University of Melbourne, Australia.
Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, Australia; Centre for Youth Mental Health, University of Melbourne, Australia.
Schizophr Res. 2018 Feb;192:345-350. doi: 10.1016/j.schres.2017.04.036. Epub 2017 Jul 31.
Psychosis and mania share conceptual, genetic and clinical features, which suggest the possibility that they have common antecedents. Participants identified to be at-risk for psychosis might also be at-risk for mania. We aimed to identify the rate and predictors of transition to mania in a cohort of youth with clinical or familial risk for psychosis.
Among a cohort of 416 young people with an at-risk mental state for psychosis defined using the Ultra-High-Risk (UHR) criteria, 74.7% were followed up between 5 and 13years from their baseline assessment. We undertook a matched case-control examination of those who developed mania over the follow-up period compared to those who did not develop mania or psychosis. Transition to mania was determined using either a structured clinical interview, or diagnoses from a state-wide public mental health contact registry. Clinical characteristics and risk factors were examined at baseline using information from structured interviews, clinical file notes, rating scales and unstructured assessments.
Eighteen participants developed mania (UHR-Manic transition or UHR-M, 4.3%). In comparison with participants matched on age, gender and baseline-study who developed neither mania nor psychosis, more UHR-M participants had subthreshold manic symptoms or were prescribed antidepressants at baseline. They also had lower global functioning.
In addition to the UHR criteria, features such as subthreshold manic symptoms and antidepressant use may help identify at-risk groups that predict the onset of mania in addition to transition to psychosis. Presence of manic symptoms may also indicate syndrome specificity early in the prodromal phase.
精神病和躁狂症在概念、遗传和临床特征上存在共通之处,这表明它们可能具有共同的前兆。患有精神病高危风险的患者也可能有患躁狂症的风险。我们旨在确定精神病高危风险人群中,出现躁狂症转变的比率及其预测因素。
在一个有精神病高危风险的队列中,有 416 名参与者符合超高危(UHR)标准,从基线评估开始,对其中 74.7%的参与者进行了 5 到 13 年的随访。我们对在随访期间发展为躁狂症的参与者与未发展为躁狂症或精神病的参与者进行了匹配病例对照研究。通过使用结构化临床访谈或全州公共心理健康联系登记处的诊断来确定躁狂症的转变。使用结构化访谈、临床档案记录、评定量表和非结构化评估来收集基线时的临床特征和风险因素。
18 名参与者发展为躁狂症(UHR-躁狂发作或 UHR-M,4.3%)。与年龄、性别和基线研究均匹配但既未发展为躁狂症也未发展为精神病的参与者相比,更多的 UHR-M 参与者在基线时有阈下躁狂症状或正在服用抗抑郁药。他们的整体功能也较低。
除了 UHR 标准外,阈下躁狂症状和抗抑郁药使用等特征可能有助于识别高危人群,这些人群除了向精神病转变外,还可以预测躁狂症的发生。在前驱期,躁狂症状的出现也可能表明综合征的特异性。